HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$16.09
Day range
$16.10 - $17.11
Year range
$3.39 - $19.40
Market cap
223.59M USD
Avg Volume
445.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.66M | 30.85% |
Net income | -20.76M | -121.09% |
Net profit margin | — | — |
Earnings per share | -1.92 | — |
EBITDA | -19.18M | -103.22% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 113.26M | 21.23% |
Total assets | 126.58M | 16.87% |
Total liabilities | 22.01M | -80.07% |
Total equity | 104.57M | — |
Shares outstanding | 13.15M | — |
Price to book | 1.67 | — |
Return on assets | -36.43% | — |
Return on capital | -42.24% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -20.76M | -121.09% |
Cash from operations | -11.39M | 30.05% |
Cash from investing | -70.86M | — |
Cash from financing | -469.00K | 0.64% |
Net change in cash | -82.72M | -393.70% |
Free cash flow | -5.56M | 95.59% |
About
Founded
2011
Headquarters
Website
Employees
23
